These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Clopidogrel: a pharmacoeconomic review of its use in patients with non-ST elevation acute coronary syndromes. Lyseng-Williamson KA; Plosker GL Pharmacoeconomics; 2006; 24(7):709-26. PubMed ID: 16802846 [TBL] [Abstract][Full Text] [Related]
28. Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular disease. Squizzato A; Keller T; Romualdi E; Middeldorp S Cochrane Database Syst Rev; 2011 Jan; (1):CD005158. PubMed ID: 21249668 [TBL] [Abstract][Full Text] [Related]
29. Thrombotic and bleeding events after coronary stenting according to clopidogrel and aspirin platelet reactivity: VerifyNow French Registry (VERIFRENCHY). Rangé G; Yayehd K; Belle L; Thuaire C; Richard P; Cazaux P; Barbou F; Köning R; Chassaing S; Teiger E; Berthier R; Decomis MP; Claudel JP; Delarche N; Brunel P; De Poli F; Dupouy P; Beygui F; Albert F; Collet JP; Montalescot G; Arch Cardiovasc Dis; 2014 Apr; 107(4):225-35. PubMed ID: 24794216 [TBL] [Abstract][Full Text] [Related]
30. Parathyroid Hormone Levels and High-Residual Platelet Reactivity in Patients Receiving Dual Antiplatelet Therapy With Acetylsalicylic Acid and Clopidogrel or Ticagrelor. Verdoia M; Pergolini P; Rolla R; Nardin M; Barbieri L; Schaffer A; Bellomo G; Marino P; Suryapranata H; De Luca G; Cardiovasc Ther; 2016 Aug; 34(4):209-15. PubMed ID: 27086085 [TBL] [Abstract][Full Text] [Related]
31. Prevention of coronary heart disease with aspirin and clopidogrel: efficacy, safety, costs and cost-effectiveness. Ho WK; Hankey GJ; Eikelboom JW Expert Opin Pharmacother; 2004 Mar; 5(3):493-503. PubMed ID: 15013918 [TBL] [Abstract][Full Text] [Related]
32. The potential role of prasugrel in secondary prevention of ischemic events in patients with acute coronary syndromes. Toth PP Postgrad Med; 2009 Jan; 121(1):59-72. PubMed ID: 19179814 [TBL] [Abstract][Full Text] [Related]
33. What is the role for improved long-term antiplatelet therapy after percutaneous coronary intervention? Steinhubl S; Berger P Am Heart J; 2003 Jun; 145(6):971-8. PubMed ID: 12796751 [TBL] [Abstract][Full Text] [Related]
34. Short- and long-term oral antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention. Mehta SR; Yusuf S J Am Coll Cardiol; 2003 Feb; 41(4 Suppl S):79S-88S. PubMed ID: 12644345 [TBL] [Abstract][Full Text] [Related]
35. Aspirin and clopidogrel in acute coronary syndromes: therapeutic insights from the CURE study. Jneid H; Bhatt DL; Corti R; Badimon JJ; Fuster V; Francis GS Arch Intern Med; 2003 May; 163(10):1145-53. PubMed ID: 12767950 [TBL] [Abstract][Full Text] [Related]
36. Clopidogrel: how good is it and how does it work? Santa-Cruz RA; Steinhubl SR Curr Cardiol Rep; 2004 Jul; 6(4):264-8. PubMed ID: 15182601 [TBL] [Abstract][Full Text] [Related]
37. Clopidogrel: a review of its use in the prevention of atherothrombosis. Jarvis B; Simpson K Drugs; 2000 Aug; 60(2):347-77. PubMed ID: 10983738 [TBL] [Abstract][Full Text] [Related]
38. Antiplatelet activity of clopidogrel in coronary artery bypass graft surgery patients. David JL; Limet R Thromb Haemost; 1999 Nov; 82(5):1417-21. PubMed ID: 10595630 [TBL] [Abstract][Full Text] [Related]
39. Prasugrel: new drug. After angioplasty and stenting: continue to use aspirin + clopidogrel. Prescrire Int; 2009 Oct; 18(103):193-5. PubMed ID: 19877380 [TBL] [Abstract][Full Text] [Related]